Literature DB >> 19969007

Nitric oxide-soluble guanylyl cyclase signaling regulates corticostriatal transmission and short-term synaptic plasticity of striatal projection neurons recorded in vivo.

Stephen Sammut1, Sarah Threlfell, Anthony R West.   

Abstract

Striatal medium-sized spiny neurons (MSNs) contain the highest levels of soluble guanylyl cyclase (sGC) in the brain. Striatal sGC signaling is activated by nitric oxide (NO) and other neuromodulators. MSNs also express cGMP-dependent protein kinase and other components of the cGMP signaling system which are critically involved in integrating corticostriatal transmission and regulating synaptic plasticity in striatal networks. However, the influence of tonic and phasic activation of this signaling pathway on striatal MSN activity is poorly understood. The present study examined the impact of systemic administration of the selective sGC inhibitor [1H-[1,2,4]oxadiazolo-[4,3-a]quinoxalin-1-one] (ODQ) on spike activity evoked using low and high frequency electrical stimulation of the frontal cortex. MSN activity was monitored using single-unit extracellular recordings in urethane-anesthetized rats. ODQ administration significantly decreased spike activity evoked by low frequency cortical stimulation in a stimulus intensity- and time-dependent manner. Additionally, ODQ administered along with the neuronal NO synthase inhibitor 7-nitroindazole (7-NI) potently decreased the incidence of excitatory responses observed during high-frequency train stimulation of the contralateral frontal cortex. The short-term depression of cortically-evoked spike activity induced by train stimulation was enhanced following pretreatment with ODQ in MSNs exhibiting an excitatory response during cortical train stimulation. Unexpectedly, this effect of ODQ was reversed in animals receiving co-administration of ODQ and 7-NI. 7-NI/ODQ co-administration also reversed measures of short-term depression observed in MSNs exhibiting an inhibitory response during cortical train stimulation. These observations extend previous studies showing that tonic and phasic NO-sGC signaling modulates the responsiveness of MSNs to corticostriatal input. Moreover, phasic activation of NO signaling is likely to regulate short-term changes in corticostriatal synaptic plasticity via complex mechanisms involving both sGC-cGMP-dependent and independent pathways. Copyright 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19969007      PMCID: PMC2813362          DOI: 10.1016/j.neuropharm.2009.11.011

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  51 in total

Review 1.  Synaptic organisation of the basal ganglia.

Authors:  J P Bolam; J J Hanley; P A Booth; M D Bevan
Journal:  J Anat       Date:  2000-05       Impact factor: 2.610

Review 2.  Impact of network activities on neuronal properties in corticothalamic systems.

Authors:  M Steriade
Journal:  J Neurophysiol       Date:  2001-07       Impact factor: 2.714

3.  Ultrastructural features of the nitric oxide synthase-containing interneurons in the nucleus accumbens and their relationship with tyrosine hydroxylase-containing terminals.

Authors:  S Hidaka; S Totterdell
Journal:  J Comp Neurol       Date:  2001-03-05       Impact factor: 3.215

4.  Nitrergic neurons make synapses on dual-input dendritic spines of neurons in the cerebral cortex and the striatum of the rat: implication for a postsynaptic action of nitric oxide.

Authors:  G Sancesario; M Morello; A Reiner; P Giacomini; R Massa; S Schoen; G Bernardi
Journal:  Neuroscience       Date:  2000       Impact factor: 3.590

5.  Involvement of NO/cGMP pathway in toluene-induced locomotor hyperactivity in female rats.

Authors:  Ming-Huan Chan; Te-Hsiung Chien; Pei-Yu Lee; Hwei-Hsien Chen
Journal:  Psychopharmacology (Berl)       Date:  2004-04-29       Impact factor: 4.530

6.  Striatum- and testis-specific phosphodiesterase PDE10A isolation and characterization of a rat PDE10A.

Authors:  K Fujishige; J Kotera; K Omori
Journal:  Eur J Biochem       Date:  1999-12

7.  Regulation of striatal dopamine neurotransmission by nitric oxide: effector pathways and signaling mechanisms.

Authors:  Anthony R West; Matthew P Galloway; Anthony A Grace
Journal:  Synapse       Date:  2002-06-15       Impact factor: 2.562

Review 8.  The neurobiology of slow synaptic transmission.

Authors:  P Greengard
Journal:  Science       Date:  2001-11-02       Impact factor: 47.728

9.  Glutamate-triggered events inducing corticostriatal long-term depression.

Authors:  P Calabresi; D Centonze; P Gubellini; G A Marfia; G Bernardi
Journal:  J Neurosci       Date:  1999-07-15       Impact factor: 6.167

10.  Dopamine and cAMP-regulated phosphoprotein 32 kDa controls both striatal long-term depression and long-term potentiation, opposing forms of synaptic plasticity.

Authors:  P Calabresi; P Gubellini; D Centonze; B Picconi; G Bernardi; K Chergui; P Svenningsson; A A Fienberg; P Greengard
Journal:  J Neurosci       Date:  2000-11-15       Impact factor: 6.167

View more
  20 in total

1.  Complex autonomous firing patterns of striatal low-threshold spike interneurons.

Authors:  Joseph A Beatty; Matthew A Sullivan; Hitoshi Morikawa; Charles J Wilson
Journal:  J Neurophysiol       Date:  2012-05-09       Impact factor: 2.714

2.  Facilitation of corticostriatal transmission following pharmacological inhibition of striatal phosphodiesterase 10A: role of nitric oxide-soluble guanylyl cyclase-cGMP signaling pathways.

Authors:  Fernando E Padovan-Neto; Stephen Sammut; Shreaya Chakroborty; Alexander M Dec; Sarah Threlfell; Peter W Campbell; Vishnu Mudrakola; John F Harms; Christopher J Schmidt; Anthony R West
Journal:  J Neurosci       Date:  2015-04-08       Impact factor: 6.167

3.  Effects of a novel phosphodiesterase 10A inhibitor in non-human primates: A therapeutic approach for schizophrenia with improved side effect profile.

Authors:  Gunasingh J Masilamoni; Subramanian Uthayathas; Gerhard Koenig; Liza Leventhal; Stella M Papa
Journal:  Neuropharmacology       Date:  2016-08-15       Impact factor: 5.250

Review 4.  Inhibition of phosphodiesterases as a strategy to achieve neuroprotection in Huntington's disease.

Authors:  Antonella Cardinale; Francesca R Fusco
Journal:  CNS Neurosci Ther       Date:  2018-03-03       Impact factor: 5.243

5.  Dopamine D4 receptors linked to protein kinase G are required for changes in dopamine release followed by locomotor activity after repeated cocaine administration.

Authors:  Jeong Hwan Oh; Dong Kun Lee; Yoon-Bo Shim; In Soo Ryu; Su Yeon Seo; Jieun Kim; Ju Hwan Yang; Hyun-Wook Cho; Eun Sang Choe
Journal:  Exp Brain Res       Date:  2015-02-22       Impact factor: 1.972

6.  Protein kinase G regulates dopamine release, ΔFosB expression, and locomotor activity after repeated cocaine administration: involvement of dopamine D2 receptors.

Authors:  Dong Kun Lee; Jeong Hwan Oh; Yoon-Bo Shim; Eun Sang Choe
Journal:  Neurochem Res       Date:  2013-04-13       Impact factor: 3.996

7.  Review: Modulation of striatal neuron activity by cyclic nucleotide signaling and phosphodiesterase inhibition.

Authors:  Sarah Threlfell; Anthony R West
Journal:  Basal Ganglia       Date:  2013-12-01

8.  Involvement of nNOS/NO/sGC/cGMP signaling pathway in cocaine sensitization and in the associated hippocampal alterations: does phosphodiesterase 5 inhibition help to drug vulnerability?

Authors:  Laura A Gabach; Valeria P Carlini; María C Monti; Laura E Maglio; Susana Rubiales De Barioglio; Mariela F Perez
Journal:  Psychopharmacology (Berl)       Date:  2013-04-12       Impact factor: 4.530

9.  Ca2+-permeable AMPA (α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid) receptors and dopamine D1 receptors regulate GluA1 trafficking in striatal neurons.

Authors:  David S Tukey; Edward B Ziff
Journal:  J Biol Chem       Date:  2013-10-16       Impact factor: 5.157

10.  Striatal Nurr1 Facilitates the Dyskinetic State and Exacerbates Levodopa-Induced Dyskinesia in a Rat Model of Parkinson's Disease.

Authors:  Rhyomi C Sellnow; Kathy Steece-Collier; Feras Altwal; Ivette M Sandoval; Jeffrey H Kordower; Timothy J Collier; Caryl E Sortwell; Anthony R West; Fredric P Manfredsson
Journal:  J Neurosci       Date:  2020-04-01       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.